Clovis Oncology (CLVS) ROA - Return on Assets

Current and historical Return on Equity (ROE) values for Clovis Oncology (CLVS) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.868B $0.056B
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.